SKY92-ISS Superior to Current Markers in Risk Classification for Myeloma Survival

News   Sep 12, 2015

 
SKY92-ISS Superior to Current Markers in Risk Classification for Myeloma Survival
 
 
 

RELATED ARTICLES

Dipstick Technology Enables Rapid Diagnosis Anywhere

News

A new Australian study has reported a revolutionary dipstick technology that allows DNA and RNA to be extracted from living organisms in as little as 30 seconds.

READ MORE

Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

READ MORE

Cancer Cells Prevent Immune Cells from Producing Cancer Killing Chemicals

News

Researchers have identified a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE